The HKAPI Annual Dinner 2023 on June 7th, held under the theme of Innovate, Integrate & Impact, was the first annual dinner event since 2019 due to the COVID-19 pandemic
We are excited to share that the HKAPI has welcomed four new members to our organization over the past year. These companies are bringing new and diverse expertise to our organization and we are thrilled to have them on board.
We are delighted to announce that our Senior Executive Director, Ms. Sabrina Chan, was invited by the Hong Kong Trade Development Council (HKTDC) to participate in the 3rd Asia Summit on Global Health (ASGH) as one of the panelists for the Project Pitching Sessions.
HKAPI has announced the election of two new members to its Board of Directors. Mr Neo Lam, from Baxter, and Mr Jonathan Chin, from Boehringer Ingelheim, have been elected to join the Board and will serve until the end of this term (2024).
We are delighted to announce that the Annual General Meeting (AGM) of the Hong Kong Association of the Pharmaceutical Industry was held successfully on 22nd March 2023.
The "Symposium - How AI is Transforming Drug Discovery and Clinical Trial Design" was a huge success, with drug developers and investors in attendance to learn about the latest AI technologies in drug discovery and clinical development.
The Hong Kong Association of Pharmaceutical Industry organized a successful briefing session for its Regulatory Intelligence Survey, attracting over 50 members to join the event.
More than 260 members attended the Code of Practice Train-the-Trainer Workshop on 11 January 2023 to understand the key changes of the Code and its implications for HKAPI members.
We are pleased to announce that Mr. Derek Chang has been elected as a Board Member of the association to fill the vacancy in the Board with effect from 9th January 2023.